Back to Newsroom
Back to Newsroom

Hoth Therapeutics, Inc. to Present at the Investor Summit on December 17th in Philadelphia

Wednesday, December 11, 2019 12:30 PM
Hoth Therapeutics

PHILADELPHIA, PA / ACCESSWIRE / December 11, 2019 / Hoth Therapeutics, Inc. (NASDAQ:HOTH), will be presenting at this year's Investor Summit on December 17th in Philadelphia.

The Investor Summit will take place at Hotel Monaco, featuring 30 companies and over 200 institutional and retail investors.

About Hoth Therapeutics, Inc.

Hoth Therapeutics is a development-stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema.

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors.

To register as a presenting company please email [email protected].

To request complimentary investor registration: please visit our website at

News Compliments of ACCESSWIRE


Please visit:

Or, contact Ashley Allard at [email protected]

SOURCE: Hoth Therapeutics

Back to newsroom
Back to Newsroom